The functions and regulation of the PTEN tumour suppressor
The DOI matches its Crossref record; 160 of the 160 references it cites were found in a registry or an index.
Abstract
The importance of the physiological function of phosphatase and tensin homologue (PTEN) is illustrated by its frequent disruption in cancer. By suppressing the phosphoinositide 3-kinase (PI3K)-AKT-mammalian target of rapamycin (mTOR) pathway through its lipid phosphatase activity, PTEN governs a plethora of cellular processes including survival, proliferation, energy metabolism and cellular architecture. Consequently, mechanisms regulating PTEN expression and function, including transcriptional regulation, post-transcriptional regulation by non-coding RNAs, post-translational modifications and protein-protein interactions, are all altered in cancer. The repertoire of PTEN functions has recently been expanded to include phosphatase-independent activities and crucial functions within the nucleus. Our increasing knowledge of PTEN and pathologies in which its function is altered will undoubtedly inform the rational design of novel therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“the majority of prostate cancer patients at presentation have lost one allele of PTEN while maintaining intact TP53; whereas TP53 mutations and the complete loss of PTEN are both associated with advanced stage prostate cancer 153,154”
From Inside and out: the activities of senescence in cancer (2014) · cites this paper as [154]
Citations
Cites
MicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Mutation and cancer: statistical study of retinoblastoma
Knudson, A. G. (1971) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.68.4.820 · Cited by 7,612
A ceRNA Hypothesis: The Rosetta Stone of a Hidden RNA Language?
Salmena, L., Poliseno, L., Tay, Y., Kats, L., & Pandolfi, P. P. (2011) · Cell · doi:10.1016/j.cell.2011.07.014 · Cited by 7,262
Self-citationAKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S. I., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., et al. (1997) · Science · doi:10.1126/science.275.5308.1943 · Cited by 4,785
Kalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism
Engelman, J. A., Luo, J., & Cantley, L. C. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1879 · Cited by 3,330
Cited by
Items 401–500 of 1,010
Troyer, D. A., Jamaspishvili, T., Wei, W., Feng, Z., Good, J. L., Hawley, S., Fazli, L., McKenney, J. K., Simko, J. P., Hurtado‐Coll, A., et al. (2015) · The Prostate · doi:10.1002/pros.23003 · Cited by 69
PTEN loss in the fallopian tube induces hyperplasia and ovarian tumor formation
Russo, A., Czarnecki, A. A., Dean, M., Modi, D., Lantvit, D. D., Hardy, L. R., Baligod, S., Davis, D. A., Wei, J., & Burdette, J. E. (2018) · Oncogene · doi:10.1038/s41388-017-0097-8 · Cited by 69
Current Approaches and Future Directions for the Treatment of mTORopathies
Karalis, V., & Bateup, H. S. (2021) · Developmental Neuroscience · doi:10.1159/000515672 · Cited by 68
Inactivation of TGF-β signaling and loss of PTEN cooperate to induce colon cancer in vivo
Yu, M., Trobridge, P. A., Wang, Y., Kanngurn, S., Morris, S. M., Knoblaugh, S. E., & Grady, W. M. (2013) · Oncogene · doi:10.1038/onc.2013.102 · Cited by 76
Regulation of Nephron Progenitor Cell Self-Renewal by Intermediary Metabolism
Liu, J., Edgington-Giordano, F., Dugas, C. M., Abrams, A., Katakam, P. V. G., Satou, R., & Saifudeen, Z. R. (2017) · Journal of the American Society of Nephrology · doi:10.1681/asn.2016111246 · Cited by 82
Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer
da Silva, H. B., Amaral, E. P., Nolasco, E. L., de Victo, N. C., Atique, R., Jank, C. C., Anschau, V., Zerbini, L. F., & Correa, R. G. (2013) · Prostate Cancer · doi:10.1155/2013/920612 · Cited by 86
Engineering ePTEN, an enhanced PTEN with increased tumor suppressor activities
Nguyen, H.-N., Yang, J.-M., Afkari, Y., Park, B. H., Sesaki, H., Devreotes, P. N., & Iijima, M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1409433111 · Cited by 83
Chen, Y., Zubović, L., Yang, F., Godin, K. S., Pavelitz, T., Castellanos, J., Macchi, P., & Varani, G. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw177 · Cited by 69
Liu, Y., Qi, X., Zeng, Z., Wang, L., Wang, J., Zhang, T., Xu, Q., Shen, C., Zhou, G., Yang, S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-03070-8 · Cited by 77
Linking single-cell measurements of mass, growth rate, and gene expression
Kimmerling, R. J., Prakadan, S. M., Gupta, A. J., Calistri, N. L., Stevens, M. M., Olçum, S., Cermak, N., Drake, R. S., Pelton, K., Smet, F. D., et al. (2018) · Genome biology · doi:10.1186/s13059-018-1576-0 · Cited by 70
Cummings, K., Watkins, A., Jones, C. A., Dias, R. P., & Welham, A. (2022) · Journal of Neurodevelopmental Disorders · doi:10.1186/s11689-021-09406-w · Cited by 71
El-Habr, E. A., Levidou, G., Trigka, E., Sakalidou, J., Piperi, C., Chatziandreou, I., Spyropoulou, A., Soldatos, R. F., Tomara, G. N., Petraki, K., et al. (2014) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-014-1641-3 · Cited by 69
Mutations in the PTEN tumor gene and risk of endometriosis: a case–control study
Govatati, S., Kodati, V. L., Deenadayal, M., Chakravarty, B., Shivaji, S., & Bhanoori, M. (2013) · Human Reproduction · doi:10.1093/humrep/det387 · Cited by 68
Brito, J. A. R., Gomes, C. C., Guimarães, A. L. S., Campos, K., & Gomez, R. S. (2013) · Journal of Oral Pathology and Medicine · doi:10.1111/jop.12112 · Cited by 74
Xiao, J., Hu, C., He, B., Chen, X., Lu, X., Xie, M., Li, W., He, S., You, S., & Chen, Q. (2016) · Oncotarget · doi:10.18632/oncotarget.11068 · Cited by 68
PTEN Regulates Glucose Transporter Recycling by Impairing SNX27 Retromer Assembly
Shinde, S. R., & Maddika, S. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.10.053 · Cited by 65
Induction of autophagy by PI3K/MTOR and PI3K/MTOR/BRD4 inhibitors suppresses HIV-1 replication
Campbell, G. R., Bruckman, R. S., Herns, S. D., Joshi, S., Durden, D. L., & Spector, S. A. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.002353 · Cited by 67
Huang, Z., Xing, S., Liu, M., Deng, W., Wang, Y., Huang, Z., Huang, Y., Huang, X., Wu, C.-W., Guo, X., et al. (2019) · Bioscience Reports · doi:10.1042/bsr20182192 · Cited by 73
PTEN Loss Mitigates the Response of Medulloblastoma to Hedgehog Pathway Inhibition
Metcalfe, C., Alicke, B., Crow, A., Lamoureux, M., Dijkgraaf, G. J. P., Peale, F. V., Jr., Gould, S. E., & de Sauvage, F. J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-13-1222 · Cited by 66
mTOR Inhibitors in Castration-Resistant Prostate Cancer: A Systematic Review
Statz, C. M., Patterson, S. E., & Mockus, S. M. (2016) · Targeted Oncology · doi:10.1007/s11523-016-0453-6 · Cited by 70
AKT-dependent and -independent pathways mediate PTEN deletion-induced CNS axon regeneration
Huang, H., Miao, L., Yang, L., Liang, F., Qizhao, W., Zhuang, P., Sun, Y., & Hu, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1289-z · Cited by 65
The mechanism of full activation of tumor suppressor PTEN at the phosphoinositide-enriched membrane
Jang, H., Smith, I. N., Eng, C., & Nussinov, R. (2021) · iScience · doi:10.1016/j.isci.2021.102438 · Cited by 66
“malignancies, acting as negative and positive regulators in the PI3K/AKT/mTOR pathway (Chalhoub and Baker, 2009; Song et al., 2012).”
BackgroundTargeting the p53 signaling pathway in cancers: Molecular mechanisms and clinical studies
Shen, J., Wang, Q., Mao, Y., Gao, W., & Duan, S. (2023) · MedComm · doi:10.1002/mco2.288 · Cited by 62
Histone H1 alterations in cancer
Scaffidi, P. (2015) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2015.09.008 · Cited by 66
Garbers, C., Kuck, F., Aparicio-Siegmund, S., Konzak, K., Kessenbrock, M., Sommerfeld, A., Häussinger, D., Lang, P., Brenner, D., Mak, T. W., et al. (2013) · Cell Cycle · doi:10.4161/cc.26431 · Cited by 64
A Unified Nomenclature and Amino Acid Numbering for Human PTEN
Pulido, R., Baker, S. J., Barata, J. T., Carracedo, A., Cid, V. J., Chin-Sang, I. D., Davé, V., den Hertog, J., Devreotes, P. N., Eickholt, B. J., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2005560 · Cited by 71
Self-citationFeedbacks, Bifurcations, and Cell Fate Decision-Making in the p53 System
Hat, B., Kochańczyk, M., Bogdał, M. N., & Lipniacki, T. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004787 · Cited by 68
Pten regulates spindle pole movement through Dlg1-mediated recruitment of Eg5 to centrosomes
van Ree, J. H., Nam, H.-J., Jeganathan, K. B., Kanakkanthara, A., & van Deursen, J. M. (2016) · Nature Cell Biology · doi:10.1038/ncb3369 · Cited by 67
Pan, F., Mao, H., Bu, F., Tong, X., Li, J., Zhang, S., Liu, X., Wang, L., Wu, L., Chen, R., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.13902 · Cited by 72
Scutellarin inhibits human renal cancer cell proliferation and migration via upregulation of PTEN
Deng, W., Han, W., Fan, T., Wang, X., Cheng, Z., Wan, B., & Chen, J. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.127 · Cited by 64
Jarome, T. J., Perez, G., Hauser, R. M., Hatch, K. M., & Lubin, F. D. (2018) · Journal of Neuroscience · doi:10.1523/jneurosci.0538-18.2018 · Cited by 66
Paletta-Silva, R., Rocco-Machado, N., & Meyer‐Fernandes, J. R. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14023683 · Cited by 77
“PTEN is involved in regulating a variety of cellular functions, including the cell cycle, apoptosis, DNA repair, signal transduction and cell adhesion [67].”
BackgroundRozengurt, E. (2014) · Frontiers in Physiology · doi:10.3389/fphys.2014.00357 · Cited by 71
Comprehensive analysis of PTEN status in breast carcinomas
Jones, N. B., Bonnet, F., Sfar, S., Lafitte, M., Lafon, D., Sierankowski, G., Brouste, V., Banneau, G., de Lara, C. T., Debled, M., et al. (2013) · International Journal of Cancer · doi:10.1002/ijc.28021 · Cited by 66
Samarakoon, R., Helo, S., Dobberfuhl, A. D., Khakoo, N. S., Falke, L. L., Overstreet, J. M., Goldschmeding, R., & Higgins, P. J. (2015) · The Journal of Pathology · doi:10.1002/path.4538 · Cited by 64
XIAO, W., Jiang, Y., Men, Q., Yuan, L., Huang, Z., Liu, T., Li, W., & LIU, X. (2014) · International Journal of Oncology · doi:10.3892/ijo.2014.2735 · Cited by 62
Connexin43 recruits PTEN and Csk to inhibit c-Src activity in glioma cells and astrocytes
González-Sánchez, A., Jaraíz-Rodríguez, M., Domínguez-Prieto, M., Herrero‐González, S., Medina, J. M., & Tabernero, A. (2016) · Oncotarget · doi:10.18632/oncotarget.10454 · Cited by 70
Using Hydrogen–Deuterium Exchange Mass Spectrometry to Examine Protein–Membrane Interactions
Vadas, O., Jenkins, M. L., Dornan, G. L., & Burke, J. E. (2016) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2016.09.008 · Cited by 74
Zhu, X., Li, Z., Li, T., Long, F., Lv, Y., Liu, L., Liu, X., & Zhan, Q. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.106 · Cited by 64
Zhang, Q., Zhang, B., Sun, L., Yan, Q., Zhang, Y., Zhang, Z., Su, Y., & Wang, C. (2018) · Cell Biochemistry and Function · doi:10.1002/cbf.3331 · Cited by 72
An, C., Jiao, B., Du, H., Tran, M., Zhou, D. F., & Wang, Y. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30574 · Cited by 66
Zhu, Z., Cao, C., Zhang, D., Zhang, Z., Liu, L., Wu, D., & Sun, J. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04596-0 · Cited by 66
Targeting the LKB1 Tumor Suppressor
Zhao, R., & Xu, Z. (2014) · Current Drug Targets · doi:10.2174/1389450114666140106095811 · Cited by 70
Protein tyrosine phosphatases as novel targets in breast cancer therapy
Nunes‐Xavier, C. E., Martín-Pérez, J., Elson, A., & Pulido, R. (2013) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.06.001 · Cited by 63
Ask1 and Akt act synergistically to promote ROS-dependent regeneration in Drosophila
Santabárbara-Ruiz, P., Esteban-Collado, J., Pérez, L., Viola, G., Abril, J. F., Milán, M., Corominas, M., & Serras, F. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1007926 · Cited by 66
miRNAs as potential game-changers in bone diseases: Future medicinal and clinical uses
Doghish, A. S., Elballal, M. S., Elazazy, O. E., Elesawy, A. E., Shahin, R. K., Midan, H. M., Sallam, A.-A. M., Elbadry, A. M. M., Mohamed, A. K. I., Ishak, N. W., et al. (2023) · Pathology - Research and Practice · doi:10.1016/j.prp.2023.154440 · Cited by 63
Shipitsin, M. V., Small, C. G., Giladi, E., Siddiqui, S., Choudhury, S. A., Hussain, S., Huang, Y. E., Chang, H., Rimm, D. L., Berman, D. M., et al. (2014) · Proteome Science · doi:10.1186/1477-5956-12-40 · Cited by 62
Tsuji‐Tamura, K., & Ogawa, M. (2016) · Journal of Cell Science · doi:10.1242/jcs.178434 · Cited by 63
Metabolic reprogramming: a hallmark of viral oncogenesis
Levy, P. L., & Bartosch, B. (2015) · Oncogene · doi:10.1038/onc.2015.479 · Cited by 69
Magdalon, J., Sánchez-Sánchez, S. M., Griesi‐Oliveira, K., & Sertie, A. L. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030659 · Cited by 60
miR-130a Deregulates PTEN and Stimulates Tumor Growth
Wei, H., Cui, R., Bahr, J. C., Zanesi, N., Luo, Z., Meng, W., Liang, G., & Croce, C. M. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0530 · Cited by 62
The Role of PTEN in Innate and Adaptive Immunity
Taylor, H. M., Laurence, A. D. J., & Uhlig, H. H. (2019) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a036996 · Cited by 60
Zhang, G., Hou, X., Li, Y., & Zhao, M. Q. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-440 · Cited by 65
Mendes, R. D., Canté-Barrett, K., Pieters, R., & Meijerink, J. P. P. (2016) · Haematologica · doi:10.3324/haematol.2016.146381 · Cited by 65
PTEN status determines chemosensitivity to proteasome inhibition in cholangiocarcinoma
Jiang, T., Pan, Y., Wan, Z., Lin, Y., Zhu, B., Yuan, Z.-G., Ma, Y., Shi, Y., Zeng, T., Dong, L., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay0152 · Cited by 65
PTEN Dual Lipid- and Protein-Phosphatase Function in Tumor Progression
Liu, A., Zhu, Y., Chen, W., Merlino, G. T., & Yu, Y. (2022) · Cancers · doi:10.3390/cancers14153666 · Cited by 76
Role of aberrant PI3K pathway activation in gallbladder tumorigenesis
Lunardi, A., Webster, K. A., Papa, A., Padmani, B., Clohessy, J. G., Bronson, R. T., & Pandolfi, P. P. (2014) · Oncotarget · doi:10.18632/oncotarget.1808 · Cited by 61
Self-citationRedox Regulation of PTEN by Peroxiredoxins
Huu, T. N., Park, J., Zhang, Y., Park, I., Yoon, H. J., Woo, H. A., & Lee, S.-R. (2021) · Antioxidants · doi:10.3390/antiox10020302 · Cited by 68
Roles of tumor suppressors in regulating tumor-associated inflammation
Yang, L., & Karin, M. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.131 · Cited by 64
Pten Loss Induces Autocrine FGF Signaling to Promote Skin Tumorigenesis
Hertzler-Schaefer, K., Mathew, G., Somani, A.-K. B., Tholpady, S. S., Kadakia, M., Chen, Y., Spandau, D. F., & Zhang, X. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.01.045 · Cited by 59
PTEN: A yin-yang master regulator protein in health and disease
Pulido, R. (2015) · Methods · doi:10.1016/j.ymeth.2015.02.009 · Cited by 70
Tay, Y., Tan, S. M., Karreth, F. A., Lieberman, J., & Pandolfi, P. P. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.06.064 · Cited by 63
Self-citationMechanism of human PTEN localization revealed by heterologous expression in Dictyostelium
Nguyen, H. N., Afkari, Y., Senoo, H., Sesaki, H., Devreotes, P. N., & Iijima, M. (2013) · Oncogene · doi:10.1038/onc.2013.507 · Cited by 61
Cleret‐Buhot, A., Zhang, Y., Planas, D., Goulet, J.-P., Monteiro, P., Gosselin, A., Wacleche, V. S., Tremblay, C. L., Jenabian, M.-A., Routy, J., et al. (2015) · Retrovirology · doi:10.1186/s12977-015-0226-9 · Cited by 72
Lissanu, Y., Shi, Y., Rai, K., Nezi, L., Amin, S. B., Wu, C.-C., Akdemir, K. C., Mahdavi, M., Peng, Q., Chang, Q., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513801113 · Cited by 67
Luo, X., Liao, R., Hanley, K. L., Zhu, H. H., Malo, K. N., Hernandez, C., Wei, X., Varki, N. M., Alderson, N., Chu, C., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.048 · Cited by 56
The Emerging Role of Polo-Like Kinase 1 in Epithelial-Mesenchymal Transition and Tumor Metastasis
Fu, Z., & Wen, D. (2017) · Cancers · doi:10.3390/cancers9100131 · Cited by 63
Lucarelli, G. T., Loizzo, D., Ferro, M., Rutigliano, M., Vartolomei, M. D., Cantiello, F., Buonerba, C., Lorenzo, G. D., Terracciano, D., COBELLI, O. D., et al. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1604223 · Cited by 62
Simultaneous Integration of Multi-omics Data Improves the Identification of Cancer Driver Modules
Silverbush, D., Cristea, S., Arad, G., Geiger, T., Beerenwinkel, N., & Sharan, R. (2019) · Cell Systems · doi:10.1016/j.cels.2019.04.005 · Cited by 61
Exploring Dysregulated Signaling Pathways in Cancer
Nisar, S., Hashem, S., Macha, M. A., Yadav, S. K., Muralitharan, S., Therachiyil, L., Sageena, G., Al‐Naemi, H. A., Haris, M., & Bhat, A. A. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200115095937 · Cited by 60
Tolcher, A. W., Kurzrock, R., Valero, V., Gonzalez, R. C., Heist, R. S., Tan, A. R., Means-Powell, J. A., Werner, T. L., Becerra, C. R., Wang, C., et al. (2020) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-020-04038-8 · Cited by 66
Wang, J., Zhou, M., Wang, X., Yang, X., Wang, M.-H., Zhang, C., Zhou, S., & Tang, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0099855 · Cited by 64
Axon plasticity in the mammalian central nervous system after injury
Chen, M., & Zheng, B. (2014) · Trends in Neurosciences · doi:10.1016/j.tins.2014.08.008 · Cited by 65
Wang, F., Li, L., Chen, Z., Zhu, M., & Gu, Y. (2016) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2518 · Cited by 57
Transposon mutagenesis identifies genes that cooperate with mutant Pten in breast cancer progression
Rangel, R., Lee, S.-C., Ban, K. H.-K., Guzman‐Rojas, L., Mann, M. B., Newberg, J. Y., Kodama, T., McNoe, L. A., Selvanesan, L., Ward, J. M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1613859113 · Cited by 58
Díaz-Serrano, A., Angulo, B., Dominguez, C., Pazo-Cid, R., Salud, A., Jiménez‐Fonseca, P., León, A., Galan, M. C., Alsina, M., Rivera, F., et al. (2018) · The Oncologist · doi:10.1634/theoncologist.2017-0379 · Cited by 64
Activation of PTEN by inhibition of TRPV4 suppresses colon cancer development
Liu, X., Zhang, P., Xie, C., Sham, K. W. Y., Ng, S. S. M., Chen, Y., & Cheng, C. H. K. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1700-4 · Cited by 67
LOTUS: A single- and multitask machine learning algorithm for the prediction of cancer driver genes
Collier, O., Stoven, V., & Vert, J. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007381 · Cited by 65
“279 Among the 20 best ranked TSGs, 4 genes are actually known TSGs that were not 280 included yet in CGCv84: PTEN [32], FAT1 [33], STAG1 [34], TRAP1 [35].”
BackgroundLi, C., Song, L., Zhang, Z., Bai, X., Cui, M., & Ma, L. (2016) · Oncotarget · doi:10.18632/oncotarget.11888 · Cited by 57
RetractedAnaplastic Thyroid Carcinoma: Current Issues in Genomics and Therapeutics
Abe, I., & Lam, A. K.-Y. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01019-9 · Cited by 63
Goschzik, T., Gessi, M., Denkhaus, D., & Pietsch, T. (2014) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0000000000000093 · Cited by 56
Chen, M., Wan, L., Zhang, J., Zhang, J., Mendez, L., Clohessy, J. G., Berry, K., Victor, J., Yin, Q., Zhu, Y., et al. (2018) · Nature Communications · doi:10.1038/s41467-017-02272-y · Cited by 71
Self-citationShin, E. J., Choi, H., Sung, M. J., Park, J. H., Chung, M., Chung, S., & Hwang, J. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.03.010 · Cited by 60
Li, Q., Li, H., Liang, J., Mei, J., Cao, Z., Zhang, L., Luo, J., Tang, Y., Huang, R., Xia, H., et al. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16347 · Cited by 64
Emerging Hallmarks of Metabolic Reprogramming in Prostate Cancer
Lasorsa, F. M., di Meo, N. A., Rutigliano, M., Ferro, M., Terracciano, D., Tătaru, O. S., Battaglia, M., Ditonno, P., & Lucarelli, G. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24020910 · Cited by 62
Predicting survival in glioblastoma with multimodal neuroimaging and machine learning
Luckett, P. H., Olufawo, M. O., Lamichhane, B., Park, K. Y., Dierker, D. L., Verastegui, G. T., Yang, P. H., Kim, A. H., Chheda, M. G., Snyder, A. Z., et al. (2023) · Journal of Neuro-Oncology · doi:10.1007/s11060-023-04439-8 · Cited by 68
PRL2/PTP4A2 Phosphatase Is Important for Hematopoietic Stem Cell Self-Renewal
Kobayashi, M., Bai, Y., Dong, Y., Yu, H., Chen, S., Gao, R., Zhang, L., Yöder, M. C., Kapur, R., Zhang, Z., et al. (2014) · Stem Cells · doi:10.1002/stem.1672 · Cited by 59
LY6E: a conductor of malignant tumor growth through modulation of the PTEN/PI3K/Akt/HIF-1 axis
Yeom, C. J., Zeng, L., Gotö, Y., Morinibu, A., Zhu, Y., Shinomiya, K., Kobayashi, M., Itasaka, S., Yoshimura, M., Hur, C., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11670 · Cited by 63
Yehia, L., & Eng, C. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0162 · Cited by 62
LncRNA DGCR5 plays a tumor-suppressive role in glioma via the miR-21/Smad7 and miR-23a/PTEN axes
He, Z., Long, J., Yang, C., Gong, B., Cheng, M., Wang, Q., & Tang, J. X. (2020) · Aging · doi:10.18632/aging.103800 · Cited by 58
Gericke, A., Leslie, N. R., Lösche, M., & Ross, A. H. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-6331-9_6 · Cited by 70
Jagan, I., Deevi, R. K., Fatehullah, A., Topley, R., Eves, J., Stevenson, M., Loughrey, M. B., Arthur, K., & Campbell, F. C. (2013) · Neoplasia · doi:10.1593/neo.121516 · Cited by 54
Wu, X., Zhou, Z.-H., & Zou, J. (2017) · Biochemistry and Cell Biology · doi:10.1139/bcb-2016-0078 · Cited by 57
RetractedSu, J., Zhou, X., Yin, X., Wang, L., Zhao, Z., Hou, Y., Zheng, N., Xia, J., & Wang, Z. P. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.05.014 · Cited by 54
Wu, R., Young, I.-C., Chen, Y.-F., Chuang, S.-T., Toubaji, A., & Wu, M. (2019) · Nature Communications · doi:10.1038/s41467-019-12184-8 · Cited by 56
A Sox2:miR-486-5p Axis Regulates Survival of GBM Cells by Inhibiting Tumor Suppressor Networks
López-Bertoni, H., Kotchetkov, I. S., Mihelson, N., Lal, B., Rui, Y., Ames, H. M., Lugo-Fagundo, M. F., Guerrero‐Cazares, H., Quiñones‐Hinojosa, A., Green, J. J., et al. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-1624 · Cited by 54
E3 ubiquitin ligase RNF126 affects bladder cancer progression through regulation of PTEN stability
Xu, H., Ju, L., Xiong, Y., Yu, M., Zhou, F., Qian, K., Wang, G., Xiao, Y., & Wang, X. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-03521-1 · Cited by 56
Haghpanah, V., Fallah, P., Tavakoli, R., Naderi, M., Samimi, H., Soleimani, M., & Larijani, B. A. (2015) · Tumor Biology · doi:10.1007/s13277-015-3923-z · Cited by 54
The HIF-1α as a Potent Inducer of the Hallmarks in Gastric Cancer
Metin, C. U., & Özcan, G. (2022) · Cancers · doi:10.3390/cancers14112711 · Cited by 58
Kawai, M., Kinoshita, S., Ozono, K., & Michigami, T. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015040446 · Cited by 59
Metadata
- Authors
- Song, M. S., Salmena, L., & Pandolfi, P. P.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Song, Min Sup
- Salmena, Leonardo
- Pandolfi, Pier Paolo
- Venue
- Nature Reviews Molecular Cell Biology
- Published
- 2012-04-04
- Volume
- 13
- Issue
- 5
- Pages
- 283-296
- ISSN
- 1471-0072 (ISSN-L)
- 1471-0080
- OpenAlex
- W2017739035
- Cited by
- 1,926
- References
- 159
- Citations by year
- 2026: 50 · 2025: 81 · 2024: 85 · 2023: 100 · 2022: 124 · 2021: 113 · 2020: 147 · 2019: 155 · 2018: 172 · 2017: 183 · 2016: 167 · 2015: 182 · 2014: 199 · 2013: 136 · 2012: 31
- FWCI
- 15.98
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature Reviews Molecular Cell Biology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- Canadian Institutes of Health Research
- National Cancer Institute (R01 CA-82328-09, R01CA082328)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- PTEN, phosphatase and tensin homologue, tumour suppressor, PI3K/AKT/mTOR pathway, lipid phosphatase activity, transcriptional regulation, non-coding RNA, post-translational modification, protein-protein interaction, cancer therapy, energy metabolism, cell proliferation
- MeSH terms
- Animals, Cell Nucleus, Gene Expression Regulation, Humans, Mutation, Neoplasms, Protein Conformation, Neoplastic Stem Cells, Signal Transduction, Tumor Suppressor Proteins, PTEN Phosphohydrolase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.